|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.040 CNY | -0.79% |
|
-6.15% | -31.61% |
| 06-01 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 05-07 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 5.18B 765M 668M 618M 576M 1.08B 72.44B 1.09B 7.34B 2.86B 35.51B 2.87B 2.81B 124B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.04B 596M 521M 481M 449M 843M 56.47B 852M 5.73B 2.23B 27.68B 2.24B 2.19B 96.37B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.41% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | -0.79% | ||
| 1 week | -6.15% | ||
| Current month | -14.29% | ||
| 1 month | -16.97% | ||
| 3 months | -13.55% | ||
| 6 months | -35.96% | ||
| Current year | -31.61% |
| 1 week | 4.81 |  | 5.31 |
| 1 month | 4.81 | | 6.14 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 10/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 23/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 10/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 10/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 23/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 10/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11-04 | Buy | Director | 100 | 0.0000% | ||
| 28/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 27/10/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.79% | -6.15% | -28.51% | -48.78% | 771M | |
| +0.32% | -2.73% | +44.49% | +143.28% | 980B | |
| +1.27% | -3.98% | +54.41% | +41.13% | 550B | |
| +6.25% | +1.00% | +24.13% | +68.06% | 382B | |
| +0.25% | -3.09% | +23.33% | +16.78% | 316B | |
| +0.42% | -1.28% | +27.89% | +14.71% | 272B | |
| +1.67% | -1.47% | +26.76% | +32.88% | 268B | |
| +2.39% | +4.42% | -36.96% | -45.12% | 199B | |
| +2.11% | -2.95% | +19.14% | +51.83% | 182B | |
| +0.90% | -0.57% | +15.09% | +60.89% | 154B | |
| Average | +1.30% | -2.94% | +16.98% | +33.57% | 330.31B | |
| Weighted average by Cap. | +1.19% | -3.50% | +31.26% | +65.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 97.59M 85.24M 78.76M 73.51M 138M 9.24B 139M 937M 364M 4.53B 366M 358M 15.77B | 624M 92.16M 80.5M 74.38M 69.42M 130M 8.72B 132M 885M 344M 4.28B 346M 338M 14.89B |
| Net income | -74.07M -10.94M -9.56M -8.83M -8.24M -15.47M -1.04B -15.64M -105M -40.84M -508M -41.09M -40.2M -1.77B | -347M -51.31M -44.81M -41.41M -38.65M -72.51M -4.86B -73.3M -492M -191M -2.38B -193M -188M -8.29B |
| Net Debt | -1.98B -293M -256M -236M -221M -414M -27.73B -419M -2.81B -1.09B -13.59B -1.1B -1.08B -47.32B | -1.14B -169M -147M -136M -127M -238M -15.97B -241M -1.62B -629M -7.83B -633M -619M -27.25B |
Employees
901
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/06/26 | 5.040 ¥ | -0.79% | 22,848,443 |
| 18/06/26 | 5.080 ¥ | +0.99% | 19,168,410 |
| 17/06/26 | 5.030 ¥ | -2.71% | 20,344,360 |
| 16/06/26 | 5.170 ¥ | -2.64% | 22,337,080 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
